A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma

Cell. 1984 Jun;37(2):511-20. doi: 10.1016/0092-8674(84)90381-7.

Abstract

We have characterized a variant Burkitt lymphoma in which translocation joins the immunoglobulin kappa locus on chromosome 2 to the c-myc gene on chromosome 8. This Burkitt lymphoma is especially interesting because, in contrast to the more common lymphomas that carry 8;14 translocations, it carries a translocation that involves a light chain locus and occurs 3' to and at least 20 kb downstream of the c-myc gene. Furthermore, the c-myc gene from the translocated chromosome is abnormally expressed in that there is a characteristic shift in c-myc promoter utilization and an increase in c-myc transcript. These disturbances could be explained by novel structural alterations that occur in the c-myc gene and include a duplication of a 2.5 kb segment of DNA containing the two c-myc promoters and their untranslated leader exons. Interestingly, these alterations arise at a considerable distance from the translocation breakpoint.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • Burkitt Lymphoma / genetics*
  • Cell Line
  • Chromosomes, Human, 1-3*
  • Chromosomes, Human, 6-12 and X*
  • DNA Restriction Enzymes
  • Genetic Variation*
  • Humans
  • Immunoglobulin Constant Regions / genetics
  • Immunoglobulin kappa-Chains / genetics
  • Oncogenes*
  • Operon
  • RNA, Messenger / genetics
  • Translocation, Genetic*

Substances

  • Immunoglobulin Constant Regions
  • Immunoglobulin kappa-Chains
  • RNA, Messenger
  • DNA Restriction Enzymes

Associated data

  • GENBANK/K01909